21st Century Oncology Holdings, Inc. - FORM 10-K - EX-12.1 - March 11, 2011

Attached files

file filename
10-K - 10-K - 21st Century Oncology Holdings, Inc.a2202627z10-k.htm
EX-3.4 - EX-3.4 - 21st Century Oncology Holdings, Inc.a2202627zex-3_4.htm
EX-32.2 - EX-32.2 - 21st Century Oncology Holdings, Inc.a2202627zex-32_2.htm
EX-31.2 - EX-31.2 - 21st Century Oncology Holdings, Inc.a2202627zex-31_2.htm
EX-31.1 - EX-31.1 - 21st Century Oncology Holdings, Inc.a2202627zex-31_1.htm
EX-23.1 - EX-23.1 - 21st Century Oncology Holdings, Inc.a2202627zex-23_1.htm
EX-21.1 - EX-21.1 - 21st Century Oncology Holdings, Inc.a2202627zex-21_1.htm
EX-14.1 - EX-14.1 - 21st Century Oncology Holdings, Inc.a2202627zex-14_1.htm
EX-32.1 - EX-32.1 - 21st Century Oncology Holdings, Inc.a2202627zex-32_1.htm
EX-10.49 - EX-10.49 - 21st Century Oncology Holdings, Inc.a2202627zex-10_49.htm
EX-10.50 - EX-10.50 - 21st Century Oncology Holdings, Inc.a2202627zex-10_50.htm
EX-10.78 - EX-10.78 - 21st Century Oncology Holdings, Inc.a2202627zex-10_78.htm
EX-10.52 - EX-10.52 - 21st Century Oncology Holdings, Inc.a2202627zex-10_52.htm
EX-10.21 - EX-10.21 - 21st Century Oncology Holdings, Inc.a2202627zex-10_21.htm

QuickLinks -- Click here to rapidly navigate through this document


Exhibit 12.1

Statement Regarding Computation of Ratio of Earnings to Fixed Charges

Radiation Therapy Services Holdings, Inc.

 
   Predecessor    
    
    
  
 
   Successor  
 
   Year Ended December 31,    
  
 
   Period From
January 1 to
February 21,
2008 		  Period From
February 22 to
December 31,
2008 		   
    
  
 
   Year Ended
December 31,
2009 		  Year Ended
December 31,
2010 		 
 
   2006   2007  
 

Pre-tax income before before adjustment for noncontrolling interests in consolidated subsidiaries

     49,886     42,644     (10,283 )   (4,266 )   (6,713 )   (126,600 )
 

(Income) Loss from equity investees

     128     46     (39 )   118     (880 )   (1,001 )
 

Distributed income of equity investees

     —     —     —     —     301     (1,007 )
 

Noncontrolling interest in pre-tax income of subsidiaries that have not incurred fixed charges

     (580 )   (1,211 )   (19 )   (2,483 )   (1,835 )   (1,698 )
 

Fixed Charges

     13,376     21,298     4,981     57,070     65,138     62,489  
                           

Earnings

     62,810     62,777     (5,361 )   50,439     56,010     (67,817 )
                           
 

Interest expense

    
12,570		    
20,250		    
4,783		    
55,863		    
63,119		    
59,098		  
 

An estimate of the interest within rental expense

     806     1,048     198     1,207     2,018     3,392  
                           

Fixed Charges

     13,376     21,298     4,981     57,070     65,138     62,489  
                           

Ratio of earnings to fixed charges

    
4.70		    
2.95		    
—		    
—		    
—		    
—		  
                           

Deficiency to cover charges(2)

    
—		    
—		    
10,341		    
6,631		    
9,128		    
130,306		  
                           
(1)
For purposes of computing the ratio of earnings to fixed charges, earnings consist of income (loss) before provision for income taxes plus fixed charges. Fixed charges consist of interest expense on all indebtness including amortization of deferred financing costs and the portion of operating lease rental expense that is representative of the interest factor.

(2)
Coverage deficiency represents the amount by which earnings were insufficient to cover fixed charges.



QuickLinks

Statement Regarding Computation of Ratio of Earnings to Fixed Charges Radiation Therapy Services Holdings, Inc.

21st Century Oncology Holdings, Inc. Reports